Diabetes antibody standardization program: first proficiency evaluation of assays for autoantibodies to zinc transporter 8.
about
Novel diabetes autoantibodies and prediction of type 1 diabetesCapillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da studyNovel Association Between Immune-Mediated Susceptibility Loci and Persistent Autoantibody Positivity in Type 1 Diabetes.Association of Type 1 Diabetes vs Type 2 Diabetes Diagnosed During Childhood and Adolescence With Complications During Teenage Years and Young Adulthood.Lack of association of type 2 diabetes susceptibility genotypes and body weight on the development of islet autoimmunity and type 1 diabetes.Extrapancreatic autoantibody profiles in type I diabetesDoes diabetes appear in distinct phenotypes in young people? Results of the diabetes mellitus incidence Cohort Registry (DiMelli).Autoantibodies to harmonin and villin are diagnostic markers in children with IPEX syndrome.Detection of Antibodies Directed to the N-Terminal Region of GAD Is Dependent on Assay Format and Contributes to Differences in the Specificity of GAD Autoantibody Assays for Type 1 Diabetes.Genetic association of zinc transporter 8 (ZnT8) autoantibodies in type 1 diabetes cases.Zinc transporter 8 autoantibodies and their association with SLC30A8 and HLA-DQ genes differ between immigrant and Swedish patients with newly diagnosed type 1 diabetes in the Better Diabetes Diagnosis studyAlternate Ways to Quantify Antibodies.Relationship between Ljungan virus antibodies, HLA-DQ8, and insulin autoantibodies in newly diagnosed type 1 diabetes children.Autoimmunity against INS-IGF2 protein expressed in human pancreatic islets.Association of serum microRNAs with islet autoimmunity, disease progression and metabolic impairment in relatives at risk of type 1 diabetes.Islet Autoantibodies.Role of humoral beta-cell autoimmunity in type 1 diabetes.Islet Autoantibody Analysis: Radioimmunoassays.Effect of a single autologous cord blood infusion on beta-cell and immune function in children with new onset type 1 diabetes: a non-randomized, controlled trial.A novel approach for the analysis of longitudinal profiles reveals delayed progression to type 1 diabetes in a subgroup of multiple-islet-autoantibody-positive children.Peptide serum markers in islet autoantibody-positive children.Incomplete immune response to coxsackie B viruses associates with early autoimmunity against insulin.Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes.Long-term sustained autoimmune response to beta cell specific zinc transporter (ZnT8, W, R, Q) in young adult patients with preserved beta cell function at diagnosis of diabetes.Glucose tolerance and beta-cell function in islet autoantibody-positive children recruited to a secondary prevention study.HLA-typing, clinical, and immunological characterization of youth with type 2 diabetes mellitus phenotype from the German/Austrian DPV database.Is there evidence for post-translational modification of beta cell autoantigens in the aetiology and pathogenesis of type 1 diabetes?Novel enzyme-linked immunosorbent assay for bivalent ZnT8 autoantibodies.Isogenic Cellular Systems Model the Impact of Genetic Risk Variants in the Pathogenesis of Type 1 Diabetes.Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 Diabetes.Prokaryotic expression and characterization of the heterodimeric construction of ZnT8 and its application for autoantibodies detection in diabetes mellitus.Optimizing Multiplexed Detections of Diabetes Antibodies via Quantitative Microfluidic Droplet Array.Type 1 Diabetes Prevention: A Goal Dependent on Accepting a Diagnosis of an Asymptomatic Disease.Validation of a rapid type 1 diabetes autoantibody screening assay for community-based screening of organ donors to identify subjects at increased risk for the disease.The dynamic changes of zinc transporter 8 autoantibodies in Czech children from the onset of Type 1 diabetes mellitus.Thyroid and Islet Autoantibodies Predict Autoimmune Thyroid Disease at Type 1 Diabetes Diagnosis.Prevalence of zinc transporter 8 antibodies in gestational diabetes mellitus.Thyroid autoimmunity in relation to islet autoantibodies and HLA-DQ genotype in newly diagnosed type 1 diabetes in children and adolescents.CD4⁺ CD45RA⁻ FoxP3high activated regulatory T cells are functionally impaired and related to residual insulin-secreting capacity in patients with type 1 diabetes.Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children.
P2860
Q27016130-587658AF-4054-4857-AE42-5E77AFD60280Q28602447-D5972A96-3F08-454D-80EC-F68DD9F722BCQ30300266-A09B80FA-5CDD-4C23-9A1E-A10E9D2E7955Q33832669-6F5D667C-C9F0-4A2F-AEB0-B84340D8952CQ34256404-C3E01855-0D1F-400C-BE63-A40EA360241DQ34428374-1037C6A0-9D84-4886-AF03-03514C6D0720Q34984676-404515FD-9802-4867-ACC0-078DAADB977AQ35046614-019BF706-A1B0-4ADA-BEFC-B7A18D4D9C4BQ35973888-32E243A8-EB25-4365-B9E8-8E7F64C15910Q36013572-1AD47DDA-2C4B-418B-8C7C-CE2C2DE1FB98Q36249785-076596DD-2BD5-41B4-AD0D-044BEB786DE8Q36366700-6FC311E4-3E81-4583-8254-7A491758A53AQ36913122-0AEDC052-5FE6-4CBE-ACAA-D254DCBB1B86Q37213887-3ED20589-DC4B-4C2F-B178-E98BF7E0B1DEQ38684417-4CC6AD35-485C-4522-8AA1-1FA6F94D73A4Q38817211-E7A9A2A4-E7AC-46EA-B94D-8481D6AFF640Q38842309-0E75B085-18AC-434C-91D5-D0E4E776EB56Q38932737-79FD66B8-053A-48A0-9789-0B96353722C1Q39337595-A7FE99D5-1517-404B-91B6-57144C25CA5CQ39613776-0F5FD7D4-AD9B-4E0F-9A36-56D3D2A5E286Q40488540-51DA441C-22A8-465B-A4CB-4C48E427B08BQ40548649-CB105D0D-F023-4D9C-B5B2-D572E8422C49Q41617660-6AB4CC75-6899-4ADE-A38B-C4A9F6D85547Q44713976-625432CA-6822-4627-AC9B-EEE98D8EAB6FQ44972607-00149C14-982A-4A30-AC97-F6F9A4995F7CQ45414033-6CAC08F2-007C-4EE9-AD81-D6F7846B720CQ45736270-F4919A3B-A45A-4790-BBE9-64D2AF52D73BQ45762287-B7464502-8FB8-4009-840C-2F67F02A6282Q45818945-F413B925-4115-4F3D-8922-AD50C329398AQ45929111-F93495DC-845C-43A4-BC1B-F2F2C3450EE0Q46556379-9ECD43AF-0133-40D4-9732-5837728FBAD9Q47153962-18F7AB5A-49D3-4C15-9F9C-BD77BA1374C9Q47594106-384E3BCF-9DA7-4737-8319-E4BDE9EE4199Q47626653-1C4BEF21-E6AE-4B67-81E6-6C2E02802E56Q47763684-6FF481C6-0496-438E-8A4D-48DBD93412C5Q47800348-C455502C-CC43-4A87-8FA7-1CF49914D332Q50916862-C1E9A482-3A41-4DCC-B8D2-F9BE65ABC76FQ51000479-22ABDDC2-E6BA-424A-868D-61A63F959477Q51052498-E7128CEA-FA06-455A-A609-CCA699046D41Q54440813-13611D66-E8B4-454C-BE9F-B7BEBEECC584
P2860
Diabetes antibody standardization program: first proficiency evaluation of assays for autoantibodies to zinc transporter 8.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Diabetes antibody standardizat ...... ibodies to zinc transporter 8.
@en
Diabetes antibody standardizat ...... ibodies to zinc transporter 8.
@nl
type
label
Diabetes antibody standardizat ...... ibodies to zinc transporter 8.
@en
Diabetes antibody standardizat ...... ibodies to zinc transporter 8.
@nl
prefLabel
Diabetes antibody standardizat ...... ibodies to zinc transporter 8.
@en
Diabetes antibody standardizat ...... ibodies to zinc transporter 8.
@nl
P2093
P1433
P1476
Diabetes antibody standardizat ...... tibodies to zinc transporter 8
@en
P2093
Janet M Wenzlau
John C Hutton
Michael Schlosser
Patricia W Mueller
Peter Achenbach
P304
P356
10.1373/CLINCHEM.2011.170662
P407
P577
2011-10-06T00:00:00Z